BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29

• Holograms For Molecules, ETH Zurich Study

  September 26, 2017

   · 

  1 min read
• Biotech Bay

  Nanoparticle Supersoap Creates ‘Bijel’ With Potential As Sculptable Fluid, Lawrence Berkeley National Laboratory Reveals

  September 26, 2017

   · 

  1 min read
• Biotech Bay

  3 Bargain Biotech Stocks You Can Buy Today

  September 26, 2017

   · 

  1 min read
• Pharm Country

  Pfizer Channels Its Inner Biotech

  September 26, 2017

   · 

  1 min read
• 

  Drug Development

  Axovant’s Much-Hyped Alzheimer’s Drug Flunks Phase III Test

  September 26, 2017

   · 

  3 min read
• Biotech Bay

  3 Reasons To Buy The Dip With Exelixis

  September 26, 2017

   · 

  1 min read
• 

  Business

  Stock Plummets as Genocea Axes 40% of Jobs, Shifts R&D Focus in Restructuring

  September 26, 2017

   · 

  2 min read
• 

  Deals

  This $4 Billion Asian Drugmaker With U.S. Ops Just Went on the Market

  September 26, 2017

   · 

  2 min read
• 

  Biotech Beach

  BioPharm Executive: Will 2017 End With a Bang or a Whimper?

  Biotech has been on fire this year, with the iShare Nasdaq Biotechnology index more than doubling the gains of the S&P 500 year-to-date.

  September 26, 2017

   · 

  7 min read
• 

  Deals

  26-Employee Cue BioPharma Seeks $40 Million IPO Eight Months After Emerging From Stealth Mode

  September 26, 2017

   · 

  2 min read